RGR Stock Analysis: Sturm Ruger | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 791m USD | 12M Return: 59.4% | US8641591081 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.1M
EPS Trend: -88.9%
Qual. Beats: 0
Rev. Trend: 77.3%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Sturm, Ruger & Company, Inc. (RGR) designs, manufactures, and sells firearms under the Ruger brand in the United States, operating through two segments: Firearms and Castings. Its product portfolio includes single-shot, autoloading, bolt-action, and modern sporting rifles; rimfire and centerfire autoloading pistols; single-action and double-action revolvers; over-under shotguns; and related accessories and replacement parts, plus lever-action rifles marketed under the Marlin name. The Castings segment supplies steel investment castings and metal injection molding (MIM) parts to third-party customers, diversifying the business beyond finished firearms.
Ruger sells its firearms to the U.S. commercial sporting market through independent wholesale distributors, while castings and MIM parts are sold directly or via manufacturers representatives. The company also exports firearms through selected commercial distributors and directly to foreign customers, primarily foreign law enforcement agencies and governments. Founded in 1949 and headquartered in Southport, Connecticut, Ruger is classified within the Consumer Discretionary sector under the Leisure Products sub-industry, reflecting its focus on recreational and sporting firearms rather than defense contracting.
- Firearms demand softens amid declining consumer discretionary spending
- Margin pressure from higher input costs and competitive pricing
- Marlin lever-action rifle product line gains market share
- Capital returns continue through special dividends despite cyclical demand headwinds
| Net Income: 16.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -5.82 > 1.0 |
| NWC/Revenue: 28.42% < 20% (prev 27.63%; Δ 0.80% < -1%) |
| CFO/TA 0.10 > 3% & CFO 37.4m > Net Income 16.4m |
| Net Debt (-98.6m) to EBITDA (40.7m): -2.42 < 3 |
| Current Ratio: 3.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.3m) vs 12m ago -0.43% < -2% |
| Gross Margin: 19.95% > 18% (prev 16.16%; Δ 3.79% > 0.5%) |
| Asset Turnover: 165.2% > 50% (prev 158.0%; Δ 7.25% > 0%) |
| Interest Coverage Ratio: 88.55 > 6 (EBIT TTM 17.8m / Interest Expense TTM 201k) |
| A: 0.45 (Total Current Assets 254.1m - Total Current Liabilities 84.1m) / Total Assets 381.7m |
| B: 1.12 (Retained Earnings 428.5m / Total Assets 381.7m) |
| C: 0.05 (EBIT TTM 17.8m / Avg Total Assets 362.0m) |
| D: 3.32 (Book Value of Equity 293.3m / Total Liabilities 88.4m) |
| Altman-Z'' = 10.39 = AAA |
| DSRI: 1.54 (Receivables 101.7m/59.9m, Revenue 598.1m/540.8m) |
| GMI: 0.81 (GM 16.16% / 19.95%) |
| AQI: -6.97 (AQ_t -1.00 / AQ_t-1 0.14) |
| SGI: 1.11 (Revenue 598.1m / 540.8m) |
| TATA: -0.05 (NI 16.4m - CFO 37.4m) / TA 381.7m) |
| Beneish M = -7.42 (Cap -4..+1) = AAA |
As of November 11, 2026, the stock is trading at USD 52.01 with a total of 279,648 shares traded. Over the past week, the price has changed by +15.27%, over one month by +18.42%, over three months by +40.71% and over the past year by +59.43%.
Current recommended Stop Loss: 49.50 (which is 4.8% or 1.2 ATR below the current price).
Sturm Ruger has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy RGR.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 43 | -17.3% |
P/E Trailing = 49.5
P/E Forward = 8.6133
P/S = 1.3702
P/B = 2.4878
Revenue TTM = 598.1m USD
EBIT TTM = 17.8m USD
EBITDA TTM = 40.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 647k USD (from shortTermDebt, last fiscal year)
Debt = 2.81m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 1.01m
Net Debt = -98.6m USD (calculated: Debt 2.81m - CCE 101.4m)
Enterprise Value = 692.3m USD (790.9m + Debt 2.81m - CCE 101.4m)
Interest Coverage Ratio = 88.55 (Ebit TTM 17.8m / Interest Expense TTM 201k)
EV/FCF = 27.47x (Enterprise Value 692.3m / FCF TTM 25.2m)
FCF Yield = 3.64% (FCF TTM 25.2m / Enterprise Value 692.3m)
FCF Margin = 4.21% (FCF TTM 25.2m / Revenue TTM 598.1m)
Net Margin = 2.74% (Net Income TTM 16.4m / Revenue TTM 598.1m)
Gross Margin = 19.95% ((Revenue TTM 598.1m - Cost of Revenue TTM 478.8m) / Revenue TTM)
Gross Margin QoQ = 20.68% (prev 21.35%)
Tobins Q-Ratio = 1.81 (Enterprise Value 692.3m / Total Assets 381.7m)
Interest Expense / Debt = 7.14% (Interest Expense 201k / Debt 2.81m)
Taxrate = 21.78% (4.57m / 21.0m)
NOPAT = 13.9m (EBIT 17.8m * (1 - 21.78%))
Current Ratio = 3.02 (Total Current Assets 254.1m / Total Current Liabilities 84.1m)
Debt / Equity = 0.01 (Debt 2.81m / totalStockholderEquity, last quarter 293.3m)
Debt / EBITDA = -2.42 (Net Debt -98.6m / EBITDA 40.7m)
Debt / FCF = -3.91 (Net Debt -98.6m / FCF TTM 25.2m)
Total Stockholder Equity = 287.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 16.4m / Total Assets 381.7m)
RoE = 5.70% (Net Income TTM 16.4m / Total Stockholder Equity 287.5m)
RoCE = 5.98% (EBIT 17.8m / Capital Employed (Total Assets 381.7m - Current Liab 84.1m))
RoIC = 5.19% (NOPAT 13.9m / Invested Capital 268.3m)
WACC = 6.57% (E(790.9m)/V(793.7m) * Re(6.57%) + D(2.81m)/V(793.7m) * Rd(7.14%) * (1-Tc(0.22)))
Discount Rate = 6.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -87.32 | Cagr: -3.40%
[DCF] Terminal Value 73.10% ; FCFF base≈32.1m ; Y1≈28.2m ; Y5≈22.8m
[DCF] Fair Price = 29.04 (EV 365.5m - Net Debt -98.6m = Equity 464.0m / Shares 16.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -88.85 | EPS CAGR: -24.05% | SUE: -0.07 | # QB: 0
Revenue Correlation: 77.27 | Revenue CAGR: 3.55% | SUE: 1.16 | # QB: 2
EPS current Quarter (2027-03-31): EPS=0.41 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=1.59 | Chg30d=-6.18% | Revisions=+0% | GrowthEPS=+89.9% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=2.02 | Chg30d=+2.27% | Revisions=+0% | GrowthEPS=+27.0% | GrowthRev=+1.6%
[Analyst] Revisions Ratio: +0% (up=0, down=0)